Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.
What the source covers
Market reports use different definitions, time periods and estimation methods. Compare those assumptions before comparing their figures.
Keep the scope clear
These independent sources do not establish a partnership with BLOPEP, certification of our products or approval of a particular batch. Follow the primary document for details and limitations.
Sources and verification scope
Peptide Therapeutics Market Report 2026 ↗
The Business Research Company
Source details (original language)
- Scope
- Publisher estimate of peptide therapeutics, 2025–2030
- Document section
- Market overview; market size and growth forecast
- Limitations
- Not a research-material market or company revenue. Segmentation and CAGR inconsistencies were not imported.
- Claim verification date
- 2026-09-09
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines ↗
Xiao et al. · Signal Transduction and Targeted Therapy
Source details (original language)
- Scope
- Historical review reporting 28 approvals in 2014–2024 and 38 phase III candidates
- Document section
- Peptide-based drug market & clinical trial; Figure 4 and Tables 2–3
- Limitations
- Denominators differ between narrative and tables; no new percentages or current regulatory count inferred.
- Claim verification date
- 2026-09-09
Therapeutic peptides: current applications and future directions ↗
Wang et al. · Signal Transduction and Targeted Therapy
Source details (original language)
- Scope
- Review of therapeutic peptide development
- Document section
- Introduction; production, modification and applications
- Limitations
- Historical review, not validation of products or batches. More than 80 approved drugs is a 2022 literature statement.
- Claim verification date
- 2026-09-09